dichlorphenamide has been researched along with Nephrocalcinosis in 1 studies
Dichlorphenamide: A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
diclofenamide : A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.
Nephrocalcinosis: A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wallace, MR | 1 |
| MacDiarmid, J | 1 |
| Reeder, J | 1 |
1 other study available for dichlorphenamide and Nephrocalcinosis
| Article | Year |
|---|---|
Exacerbation of nephrolithiasis by a carbonic anhydrase inhibitor.
Topics: Calcium; Citrates; Colorimetry; Dichlorphenamide; Glaucoma; Humans; Kidney Calculi; Male; Middle Age | 1974 |